Effectiveness of adding a workplace intervention to an inpatient multimodal occupational rehabilitation program: A randomized clinical trial
Autor: | Marit By Rise, Martin Skagseth, Marius Steiro Fimland, Petter C. Borchgrevink, Lene Aasdahl, Roar Johnsen |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Adolescent medicine.medical_treatment Occupational Health Services sick leave effectiveness Acceptance and commitment therapy Work related law.invention Young Adult Randomized controlled trial Occupational rehabilitation law Interquartile range occupational rehabilitation program Medicine Humans Single-Blind Method Musculoskeletal Diseases Workplace rct Inpatients Rehabilitation Key terms RCT business.industry Mental Disorders Hazard ratio Public Health Environmental and Occupational Health workplace intervention rtw return to work Middle Aged sickness absence randomized clinical trial Sick leave Physical therapy Original Article Female Public aspects of medicine RA1-1270 business |
Zdroj: | Scandinavian Journal of Work, Environment & Health, Vol 46, Iss 4, Pp 356-363 (2020) Scandinavian Journal of Work, Environment & Health Scandinavian Journal of Work, Environment and Health |
ISSN: | 0355-3140 |
Popis: | OBJECTIVES: This study aimed to evaluate the effectiveness of a workplace intervention (WI) added to an inpatient multimodal occupational rehabilitation program (I-MORE) on sickness absence. METHODS: In this researcher-blinded randomized controlled trial with parallel groups, individuals on sick leave due to musculoskeletal, unspecified- or common mental health disorders were randomized to I-MORE (N=87) or I-MORE+WI (N=88). I-MORE lasted 2+1 weeks (with one week at home in between) and consisted of "acceptance and commitment therapy", physical exercise, and work-related problem solving. The additional WI consisted of a preparatory part, a workplace meeting involving the sick-listed worker, the employer, and the primary rehabilitation therapist at the rehabilitation center, and follow-up work related to the meeting. The primary outcomes were number of sickness absence days and time until sustainable return to work (RTW) during 12 months of follow-up, measured by registry data. RESULTS: The median number of sickness absence days during the 12-month follow-up for I-MORE was 115 days [interquartile range (IQR) 53–183] versus 130 days (IQR 81–212) for I-MORE+WI. The difference between groups was not statistically significant (P=0.084). The hazard ratio for sustainable RTW was 0.74 (95% confidence interval 0.48–1.16; P=0.192) in favor of I-MORE. CONCLUSIONS: This study provided no evidence in favor of I-MORE+WI compared to only I-MORE for long-term sickness absent individuals with musculoskeletal-, common mental- or unspecified disorders. |
Databáze: | OpenAIRE |
Externí odkaz: |